Loading...
*  Anti-obesity Agents | Encyclopedia.com
In 1999 the FDA approved orlistat (the first of a new class of anti-obesity drugs called lipase inhibitors) for long-term use. ... Risks from Obesity Overweight and obese people are at higher risk for developing the following problems:. *sleep apnea ( ... Obesity refers to an excessively high proportion of body fat. The BMI is used to determine whether a person is overweight or ... American Obesity Association. 1250 24th Street, NW, Suite 300, Washington, DC 20037. (800)986-2373. 〈http://www.obesity.org〉. ...
  https://www.encyclopedia.com/medicine/drugs/pharmacology/anti-obesity-agents
*  Anti-Obesity Agents - Antiobesity Drugs Summary Report | CureHunter
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and ... Agents, Anti-Obesity; Agents, Antiobesity; Agents, Weight-Loss; Anti Obesity Agents; Anti Obesity Drugs; Drugs, Anti-Obesity; ... Anti-Obesity Agents (Antiobesity Drugs). Subscribe to New Research on Anti-Obesity Agents ... Antiobesity Drugs; Anti-Obesity Drugs; Antiobesity Agents; Weight-Loss Drugs; ...
  http://www.curehunter.com/public/keywordSummaryD019440-Anti-Obesity-Agents-Antiobesity-Drugs.do
*  Patent US6673815 - Substituted acid derivatives useful as antidiabetic and antiobesity agents ... - Google Patents
and a lipid-lowering agent, a lipid modulating agent, an antidiabetic agent, an anti-obesity agent, an antihypertensive agent, ... one or more anti-obesity agents, and/or one or more lipid-lowering agents, one or more lipid modulating agents (including anti- ... one or more agents for treating arthritis, one or more anti-osteoporosis agents, one or more anti-obesity agents, one or more ... anti-obesity agents, antihypertensive agents, platelet aggregation inhibitors, and/or anti-osteoporosis agents, which may be ...
  http://www.google.com/patents/US6673815?dq=6,757,682
*  Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent | Nutrition | JAMA | The JAMA Network
National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. ... National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. ... Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity AgentA Randomized Controlled Trial. ... as a Potential Antiobesity AgentA Randomized Controlled Trial. JAMA. 1998;280(18):1596-1600. doi:10.1001/jama.280.18.1596 ...
  https://jamanetwork.com/journals/jama/fullarticle/188147
*  Adifax - Serotonin reuptake inhibitor, Antiobesity Agents, Appetite Depressants, ATC:A08AA04
For the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet ... Used to treat diabetes and obesity, Dexfenfluramine decreases caloric intake by increasing serotonin levels in the brain's ...
  http://pharmacycode.com/Adifax.html
*  "Human Milk Oligosaccharide LNnT as a Novel Anti-Obesity Agent" by Meredith E. Hawkins
Current obesity treatments such as surgical procedures and anti-obesity medications have serious and undesirable side effects. ... Consequently, safer and more natural therapeutic options are being explored for anti-obesity therapy. Immunomodulatory glycans ... WAT provides no protective mechanism against obesity due to the lack of UCPJ. Obese individuals thus exhibit a deficiency in ... While several therapeutic options attempting to reverse or reduce the effects of obesity are available, safe, effective, long- ...
  https://digitalcommons.pcom.edu/biomed/150/
*  The Antiobesity Effect of Polygonum aviculare L. Ethanol Extract in High-Fat Diet-Induced Obese Mice
J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha, "The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling ... Clinically available antiobesity agents include orlistat, a pancreatic lipase inhibitor, and sibutramine, a centrally acting ... H. Choi, H. Eo, K. Park et al., "A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling ... F. Lei, X. N. Zhang, W. Wang et al., "Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced ...
  https://www.hindawi.com/journals/ecam/2013/626397/
*  Health Benefits of Bell Peppers
Anti-Obesity Agent. Capsaicin in bell pepper promotes the breakdown of large fat molecules into smaller ones. Large fat ... Anti-Microbial Activity. Bell pepper serves as a natural anti-bacterial agent and prevents bacterial and fungal growth. ... Obesity. Obesity is a condition where there is excess accumulation of body fat which poses a risk to the health of the ... Anti-Cancer Property. Red bell pepper is a great source of carotenoid pigments. Carotenoids act as an antioxidant and they are ...
  https://www.medindia.net/dietandnutrition/health-benefits-of-bell-peppers.htm
*  The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross...
General practiceAnti-obesity agentsSocioeconomic factorsWeight lossObesityMulti-level modelling ... are more likely to be prescribed anti-obesity medication.. What is already known on this topic. Anti-obesity medication has ... relate uptake of anti-obesity medications to need and; 2) quantify the amount of variation in prescribing of anti-obesity ... Prescribing of anti-obesity medication reflected obesity prevalence across urban/rural areas and deprivation. There was an ...
  https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-87
*  Patent US7718400 - Methods of increasing lean tissue mass using OB protein compositions - Google Patents
Anti-obesity agents. WO1997000319A2. Jun 11, 1996. Jan 3, 1997. Smithkline Beecham Plc. Chimeric leptin fused to immunoglobulin ... Thus, OB protein has the capacity to act, in addition to acting as a weight reducing agent, as an agent affecting lean tissue ... additives such as detergents and solubilizing agents (e.g., Tween 80, Polysorbate 80), anti-oxidants (e.g., ascorbic acid, ... The therapeutic agent could also be given in a film coated tablet and the materials used in this instance are divided into 2 ...
  http://www.google.com/patents/US7718400?dq=3657699
*  Patent US20070269522 - Transdermal Drug Delivery Device with Translucent Protective Film - Google Patents
... drug delivery device comprising a reservoir comprising a releasably stored dosage of a pharmaceutically active agent and a ... anticancer agents (e.g., methotrexate); neurologic agents such as anxiolytic drugs; hemostatics; anti-obesity agents; and the ... Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent. ... antimigraine agents (e.g., ergotamine, melatonin, sumatripan); antiarrhythmic agents (e.g., flecainide); antiemetics (e.g., ...
  http://www.google.ca/patents/US20070269522
*  Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide...
Hypoglycemic Agents. Physiological Effects of Drugs. Appetite Depressants. Anti-Obesity Agents. Amylin Receptor Agonists. ... Number of Participants With Treatment Emergent Positive Anti-leptin Antibody Titers at Week 52 and at Follow up by Metreleptin ...
  https://clinicaltrials.gov/show/NCT00819234
*  Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children - Full Text View - ClinicalTrials.gov
Neuroprotective Agents. Protective Agents. Physiological Effects of Drugs. Anti-Obesity Agents. To Top ... Decreased use of acute therapies (e.g. anti-emetics). *Decreased emergency department visits.. ... Significant major psychiatric disorder (e.g., major depression) or subjects receiving anti-psychotic medication. ...
  https://clinicaltrials.gov/ct2/show/NCT00286988?cond=%22cyclic+vomiting+syndrome%22&rank=4
*  Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients - Full Text View - ClinicalTrials.gov
Obesity. Anti-Obesity Agents. Carbonic Anhydrase. Carbonic Anhydrase Inhibitors. Enzyme Inhibitors. Sulfonamides. Therapeutic ... Sleep Apnea Obstructive Sleep Apnea Obesity Drug: Zonisamide Drug: Placebo Device: nCPAP Phase 2 ... Obesity. Apnea. Overweight. Overnutrition. Nutrition Disorders. Body Weight. Signs and Symptoms. Respiration Disorders. ...
  https://clinicaltrials.gov/ct2/show/NCT01765608?cond=%22Sleep+Apnea+Syndromes%22&rank=8
*  Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine - Full Text View - ClinicalTrials...
Neurotransmitter Agents. Serotonin Agents. Anticonvulsants. Neuroprotective Agents. Protective Agents. Anti-Obesity Agents. ... Autonomic Agents. Peripheral Nervous System Agents. Physiological Effects of Drugs. Gastrointestinal Agents. Antipsychotic ... Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Serotonin Uptake Inhibitors. Neurotransmitter ...
  https://clinicaltrials.gov/ct2/show/NCT00394095
*  The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes - Full Text View - ClinicalTrials.gov
Hypoglycemic Agents. Physiological Effects of Drugs. Appetite Depressants. Anti-Obesity Agents. Amylin Receptor Agonists. ...
  https://clinicaltrials.gov/ct2/show/NCT00206297
*  Scotland Is Not For The Squeamish 2011
pursue You human Anti-Aging Products in Your theories and IDs? new Wrinkle ia have always returned at ermitteln over 40 but ... The Dictionary of Untranslatables offers, for safety, to write on the registration between the others l, Geist, and agent. Or ... have 9HD have in Program and bc1q9x30z7rz52c97jwc2j79w76y7l3ny54nlvd4ewLTC? obesity is a high experience of equipment that, ... The insight you widely noted decentralised the profession user-agent. There have sociocultural institutes that could run this ...
  http://keepergoals.com/Templates/pdf/Scotland-is-not-for-the-squeamish-2011/
*  Biomedical & Health Informatics
Anti-Aging Skin Care - Wound Care Europe 2018 (Italy). *Applied Health Economics and Health Policy - Health Economics 2018 ( ... Disease Causing Agents - Tropical Diseases Congress 2018 (Spain). *Disease prevention and health promotion interventions - ... Obesity & Public Health - Global Public Health 2018 (Hong Kong). *Obesity & Public Health - Public Health Summit 2018 (Japan) ...
  https://publichealthcongress.conferenceseries.com/events-list/biomedical-health-informatics